Advertisement

False positive pregnancy tests in pediatric patients with augmentation enterocystoplasty

Published:September 13, 2022DOI:https://doi.org/10.1016/j.jpurol.2022.09.008

      Summary

      Purpose

      Our primary aim was to determine the prevalence of positive over-the-counter (OTC) pregnancy tests among pediatric female and male patients who had undergone augmentation enterocystoplasty. A secondary aim was to determine whether patient factors or urinalysis (UA) results were associated with false positive OTC pregnancy test results in patients with a history of augmentation enterocystoplasty.

      Methods

      Patients at a tertiary pediatric hospital who had previously undergone augmentation enterocystoplasty, Mitrofanoff appendicovesicostomy only, and age- and sex-matched controls were prospectively recruited. Urine samples were obtained, and two OTC pregnancy tests were conducted – OTC Test A reported the ability to detect pregnancy at hCG levels as low as 9.6 mIU/mL, while OTC Test B reported positive pregnancy test results at hCG levels ≥25 mIU/mL. A point of care (POC) pregnancy test and UA were also completed. Mann–Whitney U tests and Fisher's exact tests were used to assess whether patient factors or UA results were associated with false positive pregnancy test results.

      Results

      Fifty pediatric patients were enrolled, including 20 with augmentation enterocystoplasty, 20 age- and sex-matched controls, and 10 with Mitrofanoff appendicovesicostomy only. Among the 20 patients who had undergone augmentation cystoplasty, 15 (75.0%) had positive pregnancy test results on OTC Test A, including 11/13 (84.6%) females and 4/7 (57.1%) males. No control patients or patients with Mitrofanoff appendicovesicostomy only had a positive test. No patients had positive pregnancy test results on OTC Test B or the POC test. While patients with augmentation enterocystoplasty were significantly more likely to test positive for blood (p = 0.01), nitrate (p = 0.03), and leukocytes (p < 0.0001), these factors were not significantly associated with false positive pregnancy results. No patient factors or UA results were associated with increased likelihood of false positive OTC pregnancy test results.

      Conclusions

      Summary Figure
      Graphical AbstractPatient Characteristics and Over-the-Counter Pregnancy Test Results among 20 Patients with Bladder Augmentation, 20 Controls, and 10 Patients with Mitrofanoff Appendicovesicostomy only.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Journal of Pediatric Urology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Cole L.A.
        • Sutton-Riley J.M.
        • Khanlian S.A.
        • Borkovskaya M.
        • Rayburn B.B.
        • Rayburn W.F.
        Sensitivity of over-the-counter pregnancy tests: comparison of utility and marketing messages.
        J Amer Pharm Associ. 2005; 45: 608-615
        • Tomlinson C.
        • Marshall J.
        • Ellis J.E.
        Comparison of accuracy and certainty of results of six home pregnancy tests available over-the-counter.
        Curr Med Res Opin. 2008; : 1645-1649
        • Schanne F.J.
        • Cooper C.S.
        • Canning A.D.
        False-positive pregnancy test associated with gonadoblastoma.
        Urology. 1999; 54: 162
        • McCash S.I.
        • Goldfrank D.J.
        • Pessin M.S.
        • Ramanathan L.V.
        Reducing false-positive pregnancy tests in cancer patients.
        Obstet Gynecol. 2017; 130: 825-829
        • Deltombe M.
        • Nevraumont A.
        • Guillaume L.
        • Bayart J.L.
        • Gruson D.
        False-positive pregnancy test: beware of familial hCG syndrome.
        Clin Chem Lab Med. 2021; 59: e424-e425
        • Buckner C.L.
        • Wilson L.
        • Papadea C.N.
        An unusual cause of elevated serum total beta hCG.
        Ann Clin Lab Sci. 2007; 37: 186-191
        • Kountz D.S.
        • Kolander S.A.
        • Rozovsky A.
        False positive urinary pregnancy test in the nephrotic syndrome.
        N Engl J Med. 1989; 321: 1416
        • Nakhal R.S.
        • Wood D.
        • Woodhouse C.
        • Creighton S.M.
        False-positive pregnancy tests following enterocystoplasty.
        BJOG. 2012; 119: 36-368
        • Nethercliffe J.
        • Trewick A.
        • Samuel C.
        • Leaver R.
        • Woodhouse C.R.J.
        False-positive pregnancy tests in patients with enterocystoplasties.
        BJU Int. 2001; 87: 780-782
      1. Food and Drug Administration 510(k) Substantial Equivalence Determination: Decision Summary Assay Only Template: k060128.
      2. Food and Drug Administration 510(k) Substantial Equivalence Determination: Decision Summary Assay Only Template: k132085.
      3. Cardinal Health hCG Cassette SP™ Brand Rapid test. Cardinal health, McGaw Park, IL.

        • Mital R.
        • Forster M.
        • Alloghbi A.
        • Kayyali A.
        A case of a false-positive urine pregnancy test and delayed diagnosis of obstructive pyelonephritis.
        Am J Case Rep. 2020; 21e920440
        • Soni S.
        • Menon M.C.
        • Bhaskaran M.
        • Jhaveri K.D.
        • Molmenti E.
        • Muoio V.
        Elevated human chorionic gonadotropin levels in patients with chronic kidney disease: case series and review of literature.
        Indian J Nephrol. 2013; 23: 424-427
        • Braunstein G.D.
        False-positive serum human chorionic gonadotropin results: causes, characteristics, and recognition.
        Am J Obstet Gynecol. 2002; 187: 217-224
        • Sugimoto K.
        • Hashimoto K.
        • Esa A.
        • Park Y.C.
        Beta-hCG producing urothelial carcinoma of the urinary bladder: a case report.
        Hinyokika Kiyo. 2008; 54: 289-292
        • Rajabi B.
        • Khoury J.
        • Brewer C.
        • Goodman Jr., O.B.
        Urothelial bladder carcinoma with choriocarcinomatous differentiation presenting with a false-positive pregnancy test.
        Am J Med Sci. 2013; 346: 256-258
        • Andruska N.
        • Mahapatra L.
        • Brenneman R.
        • MacArthur K.M.
        • Oppelt P.
        • Baumann B.C.
        False-positive pregnancy test secondary to ectopic expression of human chorionic gonadotropin by a gastrointestinal stromal tumor.
        J Surg Oncol. 2020; 122: 809-812
        • Iles R.
        • Oliver R.
        • Kitau M.
        • Walker C.
        • Chard T.
        In vitro secretion of human chorionic gonadotrophin by bladder tumour cells.
        Br J Cancer. 1987; 55: 623-626
        • Iles R.K.
        • Chard T.
        Immunochemical analysis of the human chorionic gonadotrophin-like material secreted by 'normal' and neoplastic urothelial cells.
        J Mol Endocrinol. 1989; 2: 107-112